AbbVie and Cugene have teamed up to research autoimmune diseases and cancer in an exclusive…
Latest news
Do you want to be part of the largest gathering of mRNA professionals? The 2nd Annual mRNA-Based…
As the world and the UK continues its march out of the pandemic’s shadow, the…
BenevolentAI has discovered a second novel target for idiopathic pulmonary fibrosis (IPF), which AstraZeneca has…
AstraZeneca has boosted its research capacity by extending its oncology partnership with Proteros biostructures. German…
Strategic coaching is bringing rewards across pharma as the industry adjusts to post-pandemic practices and…
A digital health startup accelerator is launching in Italy, with more than €6 million backing…
An albuterol/budesonide fixed-dose combination rescue medication has been shown to reduce severe exacerbations in patients…
An early-stage drug that is being developed to tackle inflammatory and autoimmune diseases has been…
Blood sugar control drug Mounjaro has been granted US regulatory approval, giving type 2 diabetics…
Adele Waugaman, senior digital health coordinator of the COVID-19 response at the United States Agency…
When it comes to enthusiasm about digital innovation, pharma seems to be more adept at…
This post was originally published on Source Link
The unprecedented rate of digital acceleration seen in the first two years of COVID-19 has…
The FDA has delivered a blow to UCB’s late-stage pipeline, after saying it is unable…
Around 4,500 women in the UK will be eligible for treatment with Gedeon Richter’s once-daily…
Arkansas has become the latest US state to issue a legal challenge to the big…
Bristol-Myers Squibb’s flurry of dealmaking has continued with en expansion of its partnership with BridgeBio…
German drugmaker Boehringer Ingelheim has sold an artificial intelligence-powered software platform it developed to monitor…
People who trust pharma are more interested in using the industry’s services – making building…
AbbVie’s would-be blockbuster Rinvoq has notched up another positive trial in Crohn’s disease, showing that…
Johnson & Johnson has appointed Thibaut Mongon as the chief executive of its consumer health…
Bristol-Myers Squibb’s Celgene unit has clearly been impressed by progress in its four-year-old alliance with…
AbbVie’s Allergan subsidiary and Teva are reportedly considering making a $5 billion-plus offer to try…
- Pharma News
Content Factory 24/7: Viseven adds a Center of Excellence in India to provide around-the-clock global support for its clients
TALLINN, Estonia, May 11, 2022 – Viseven is proud to announce its latest venture –…
US digital health firm Osmind – which had developed an electronic health record (EHR) system…
Antimicrobial resistance is a growing problem and one that is already claiming over a million…
Danish drugmaker Novo Nordisk has traditionally generated its pipeline mainly from internal R&D, but a…
A pooled analysis of data for AstraZeneca and Sanofi’s respiratory syncytial virus (RSV) antibody nirsevimab…
Roche’s anti-TIGIT antibody tiragolumab has failed a second phase 3 trial, dousing expectations for the…
Not content with a $1.2 billion licensing deal for Biohaven Pharma’s oral migraine therapy rimegepant,…
Jamie Phares, managing director, The Janssen Pharmaceutical Companies of Johnson & Johnson in the Gulf…
Administering a fourth dose of an mRNA COVID-19 vaccine provides a stronger level of protection…
Researchers in the US have developed a wearable monitor that could be used to monitor…
Engaging, strategic, customer-centric communication is important in any industry, and no industry has been unaffected…
Here we go again. With Aduhelm largely sidelined, Biogen and Eisai are hoping for a…
Roche has elevated a longstanding alliance with Finland’s Kaiku Health focusing on digital patient monitoring…
Seagen’s chief executive Clay Siegall has taken leave of absence pending an investigation into an…
Shares in Belgian biotech Oxurion are taking a hammering this morning after it reported that…
Mental health issues among teens and young adults have risen dramatically over the past decade.…
Adding Nykode Therapeutics’ VB10.16 vaccine to treatment with Roche’s cancer immunotherapy Tecentriq resulted in disease…
Johnson & Johnson has halved the size of its collaboration with Bavarian Nordic on vaccines…
A new “black cheque” company that claims to be the first in Europe devoted to…
A study has shown that a mobile game can be used to gather symptom data…
This post was originally published on Source Link
The PING Conference 2022 is back in person this year, with opportunities to network face-to-face…
Throughout my 30-year career, there have been many times it was obvious I stood out…
Sanofi has completed the spin-out of its pharma ingredients business EuroAPI, with shares in the…
Biogen has licensed rights to a digital therapeutic (DTx) developed by MedRhythms which combines sensors,…
A digital therapeutic (DTx) developed to help people suffering from insomnia has been shown to…